About Amazentis
Amazentis is a Healthcare company based in Lausanne (Switzerland) founded in 2007. Developing nutritional products to slow aging and improve quality of life. Amazentis has raised $8.9 million across 2 funding rounds from investors including Nestlé Health Science. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. Amazentis offers products and services including Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific.
Company details
Amazentis is a biotechnology company based in Switzerland that is developing innovative nutritional products to combat aging and improve the quality of life. Amazentis focus is on harnessing the effects of Urolithin A on aging mitochondria - a finding that the founders reported in a landmark research article in the journal Nature Medicine where they showed that Urolithin A induces mitophagy and prolong life span in nematodes, and improves muscle function in rodents. Urolithin A is produced naturally by human gut bacteria by the conversion of ellagitannins - natural precursor compounds found in, among others, pomegranates. Once taken up by cells, Urolithin A acts by preventing the accumulation of dysfunctional mitochondria in aging cells.
- Headquarters Lausanne, Switzerland
- SectorsHealthcare
- Email••••••••
- Website amazentis.com
- Social LinkedIn YouTube
- Legal Name Ironsource India Private Limited
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Total Equity Funding$8.9M (USD)
in 2 rounds
- Investors
Associated legal entities of Amazentis
Amazentis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Products & Services of Amazentis
Amazentis offers a comprehensive portfolio of products and services, including Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum.
Dietary supplement for cellular energy and health support.
Cream that strengthens skin barrier and reduces aging signs.
Powder for daily health routine and mitochondrial benefits.
Cream for skin regeneration and resilience overnight.
Serum that lifts and firms skin with Urolithin A.
Apps and channels of Amazentis
its YouTube channel Timeline has 1.93K subscribers and 26 videos.
Videos from Amazentis
The most watched videos on Amazentis's YouTube channel, Timeline (1.93K subscribers). Click a video to play it here.
More on Timeline.
Funding Insights of Amazentis
Amazentis has successfully raised a total of $8.9M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.9M
- Total Rounds 2
- First Round $8.9M
(Mar 2018)
- Investors Count 1
All 2 funding rounds of Amazentis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | Series C | – | Nestlé Health Science | – | |
| Mar 2018 | $8.9M | Series C | – | – | – |
1 investors in total: 1 institutional.
Investors in Amazentis
Amazentis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nestlé Health Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Nutritional dietary supplements are provided for health and wellness needs. | 2011 | nestlehealthscience.com | Epalinges, Switzerland |
Investor details for Amazentis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ironsource India Private Limited (Amazentis)
Ironsource India Private Limited is the primary company behind Amazentis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
People of Amazentis
26 people are tracked at Amazentis (14 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Eva Le Garrec | Global Brand Director - Skin | Leadership |
Davide D'Amico | Director Of Discovery And Translational Research | Leadership |
Katrina A. | Director, Growth Marketing | Leadership |
Dennis Mouzakis | Vice President Supply Chain | Leadership |
Isha Suhag | Head Of Design | Leadership |
Andy M. | Chief People Officer | Leadership |
Bethany McElligott | Director, Lifecycle Marketing | Leadership |
Chris R. | President, Co-founder And Board Member | Leadership |
Anurag Singh | Chief Medical Officer | Leadership |
Mateo Abrecht | Ecommerce Senior Manager & Head Of Analytics | Leadership |
Julie Dixon | Director Of Manufacturing And Logistics | Leadership |
Federico Luna | Chief Marketing & E-Commerce Officer | Leadership |
Molly Crabtree-Maul | Executive Creative Director | Leadership |
Ian Davison | VP Brand Marketing | Leadership |
Sarah Marini | Senior Manager, Partnerships | Team |
Paula Neiman | Manager, Field Marketing | Team |
Sean G. | Senior Manager, Influencer Marketing — Skin | Team |
Jennifer Scheinman, MS, RDN | Senior Manager Nutrition Affairs | Team |
Emily N. Werner | Nutrition Affairs | Team |
Samantha Nelson | Email Marketing Manager | Team |
6 more people are available in the full profile.
Complete people profiles for Amazentis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Amazentis
Figures of Ironsource India Private Limited, the primary company behind Amazentis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for Amazentis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Amazentis
3 dated milestones of Amazentis across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Amazentis is founded.
- Funding First funding round of $8.9M.
- Funding Latest funding round, Series C,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amazentis
Complete news archive for Amazentis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amazentis
Amazentis was founded in 2007 and raised its 1st funding round 11 years after it was founded.
Amazentis is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Amazentis is a funded company, having raised a total of $8.9M across 2 funding rounds to date. The company's 1st funding round was a Series C of $8.9M, raised on Mar 2018.
The primary company behind Amazentis, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
Amazentis is a biotechnology company based in Switzerland that is developing innovative nutritional products to combat aging and improve the quality of life. Amazentis focus is on harnessing the effects of Urolithin A on aging mitochondria - a finding that the founders reported in a landmark research article in the journal Nature Medicine where they showed that Urolithin A induces mitophagy and prolong life span in nematodes, and improves muscle function in rodents. Urolithin A is produced naturally by human gut bacteria by the conversion of ellagitannins - natural precursor compounds found in, among others, pomegranates. Once taken up by cells, Urolithin A acts by preventing the accumulation of dysfunctional mitochondria in aging cells.
Amazentis offers Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum.
Amazentis has 1 investor. Key investors include Nestlé Health Science.
Amazentis operates through Ironsource India Private Limited.
The legal entities of Amazentis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.